Press releases
-
ICON reports fourth quarter and full year 2015 results and issues 2016 earnings guidance
In the fourth quarter net revenue grew 3.4% year on year to $403.3 million from $390
-
ICON selected by Genomics England
ICON selected by Genomics England to support the largest genome sequencing project of its kind for cancer and rare diseases
-
ICON Accelerates Site Activation Timelines by up to 25%
ICON announce that it has accelerated its study start-up timelines globally and has achieved a reduction of mean start-up cycle times by up to 25% -
ICON acquires PMG Research Inc.
Acquisition enhances ICON’s site and patient engagement capabilities
-
ICON Partners with iCardiac Technologies
The partnership aims to provide an earlier and more precise method for evaluating cardiac safety. -
ICON reports third quarter 2015
In the third quarter net revenue grew 1.8% year on year to $394.7 million.
-
ICON Strengthens its Leadership Team in Asia Pacific with Two Key Appointments
Mary Pan is new VP of Asia Pacific and Hiroshi Ichikawa leads ICON’s operations in Japan. -
ICON Receives Finalist Nomination for the 2015 Scrip Awards
Firecrest eConsent shortlisted in best technological development in Clinical Trials category. -
ICON and IBM to revolutionise clinical trials
ICON applies IBM Watson clinical trial matching to oncology clinical trials.
-
ICON Launches Medical Device & Diagnostics Research Group
Dedicated services to support medical device manufacturers throughout the product lifecycle.
